Elbaset Mohamed A, Osman Yasser, Elgamal Mostafa, Sharaf Mohamed A, Ezzat Osama, Elmeniar Ali M, Abdelhamid Abdalla, Zahran Mohamad H
Department of Urology, Urology and Nephrology Center, Mansoura University, Mansoura, Egypt.
Department of Radiology, Urology and Nephrology Center, Mansoura University, Mansoura, Egypt.
Arab J Urol. 2020 Sep 2;19(2):173-178. doi: 10.1080/2090598X.2020.1816600.
: To assess the long-term outcomes after pyeloplasty for pelvi-ureteric junction obstruction (PUJO) associated with renal anomalies. : Data were collected for patients after pyeloplasty for PUJO associated with renal anomalies and analysed retrospectively. Long-term functional success was evaluated by comparing the renographic split renal function (SRF) and glomerular filtration rate (GFR) at last follow-up with baseline values. A change of 5% in SRF was considered significant. Factors affecting functional outcome were assessed. The outcomes were compared to an age, sex and renal function matched group with PUJO in otherwise normal kidneys (Group 2) to evaluate the pattern of difference in functional recoverability in both groups. This was assessed using repeated-measures analysis of variance. : The study initially included 70 adult patients, with a mean age of 31.8 years. At a median of 44 months, 55 patients completed follow-up (Group 1) and no statistically significant changes in GFR ( = 0.7) and SRF ( = 0.06) were found. In all, 17, four and 34 patients showed a decrease, increase and static SRF (functional success rate was 69%). Higher preoperative SRF ( = 0.02) and Anderson-Hynes (A-H) pyeloplasty ( = 0.003) were associated with functional preservation. In the comparison with the other matched group (Group 2), the patients in Group 2 had better functional recoverability after pyeloplasty than patients with associated anomalies [GFR ( = 0.001), SRF ( = 0.002) and functional success ( = 0.001)]. : Functional preservation after pyeloplasty in associated renal anomalies could be achieved in 69% of patients, which was significantly lower than those with otherwise normal kidneys. A-H pyeloplasty and higher preoperative SRF were associated with better functional outcomes. : A-H: Anderson-Hynes; HSK: horseshoe kidneys; OR: odds ratio; PUJO: PUJ obstruction; SRF: split renal function; T, half-time.
评估肾盂成形术治疗合并肾异常的肾盂输尿管连接部梗阻(PUJO)后的长期疗效。收集肾盂成形术治疗合并肾异常的PUJO患者的数据并进行回顾性分析。通过比较最后一次随访时的肾图分肾功能(SRF)和肾小球滤过率(GFR)与基线值来评估长期功能成功率。SRF变化5%被认为具有显著性。评估影响功能结局的因素。将结局与年龄、性别和肾功能匹配的单纯PUJO(无其他肾脏异常)组(第2组)进行比较,以评估两组功能恢复能力的差异模式。使用重复测量方差分析进行评估。该研究最初纳入70例成年患者,平均年龄31.8岁。在中位随访44个月时,55例患者完成随访(第1组),未发现GFR(P = 0.7)和SRF(P = 0.06)有统计学显著变化。总体而言,17例、4例和34例患者的SRF分别出现下降、升高和稳定(功能成功率为69%)。术前SRF较高(P = 0.02)和安德森 - 海因斯(A - H)肾盂成形术(P = 0.003)与功能保留相关。与另一匹配组(第2组)相比,第2组患者肾盂成形术后的功能恢复能力优于合并异常的患者[GFR(P = 0.001)、SRF(P = 0.002)和功能成功率(P = 0.001)]。合并肾异常患者肾盂成形术后69%可实现功能保留,显著低于无其他肾脏异常的患者。A - H肾盂成形术和较高的术前SRF与更好的功能结局相关。A - H:安德森 - 海因斯;HSK:马蹄肾;OR:比值比;PUJO:PUJ梗阻;SRF:分肾功能;T,半衰期